Custom service
Codon Optimization
The sequence before the sequence — where expression yield is decided.
Codon optimisation is routinely reduced to matching codon usage tables, which is why it routinely disappoints. The codon a host prefers matters, but expression is decided by more than that: mRNA secondary structure around the start codon, ribosome pausing sites, cryptic splice sites in mammalian cells, RNA instability motifs, internal TATA boxes, and — for secreted proteins — the interaction of codon usage with the signal peptide's translation kinetics.
Optimisation is a constraint-satisfaction problem, not a substitution problem. The protein sequence is fixed; the coding choices must satisfy the host's codon preferences, avoid the motifs that damage expression, preserve any regulatory features the construct depends on, and — where a rare codon deliberately slows translation to let a domain fold — preserve that pause rather than smooth it away. Optimising everything to maximum speed can hurt proteins whose folding depends on co-translational timing.
The deliverable is a sequence with its reasoning. Codon adaptation index, predicted mRNA structures, avoided motifs and the deliberate pauses are documented, and the sequence is verified by synthesis and expression where the project continues into production. When two plausible designs exist, both are synthesised in small scale — the difference between them is measured, not argued.
Codon optimisation matters most for heterologous expression of proteins from GC-rich or AT-rich genomes, for high-yield production, and for mammalian constructs carrying cryptic splice sites that fragment the transcript.
It is a low-value investment for a protein that already expresses acceptably, and it cannot rescue a construct whose problem is the protein itself — insolubility and misfolding are protein properties, not codon properties.
Every optimised sequence is verified against the protein sequence it encodes, checked for the screened motifs, and delivered with the design rationale. Where an A/B comparison was run, both sequences' expression data are included and the choice is documented by measurement.
Service Highlights
- Host-specific tables. Codon usage from measured host data — E. coli strain, CHO, HEK293, insect, Pichia, plant — not generic tables.
- Start-codon structure control. MRNA secondary structure around the initiation region modelled and avoided or preserved deliberately.
- Motif screening. Cryptic splice sites, polyadenylation signals, RNA instability motifs and internal promoters screened and removed.
- Translational pauses preserved. Rare codons that pace domain folding retained where the protein's folding requires them.
- Signal peptide aware. Codon choices checked against the signal peptide's translation kinetics for secreted targets.
- A/B design comparison. Where the optimal design is ambiguous, two variants are synthesised and compared empirically.
How the work runs
Host and context review
Expression host, vector, promoter and protein class reviewed, since all four change what the sequence should look like.
Sequence optimisation
Codon choices optimised with motif screening and structure modelling applied simultaneously.
Constraint check
Protein sequence integrity confirmed; deliberate pauses and regulatory features preserved or deliberately removed.
Alternative design
Where the design space is ambiguous, a second sequence generated for comparison.
Verification
Synthesis and sequence confirmation; small-scale expression comparison where the project continues.
Delivery
Optimised sequence, design report and, where expressed, the comparison data.
Specifications & timeline
- Hosts
- E. coli (per strain), CHO, HEK293, Sf9, Pichia, S. cerevisiae, plant
- Checks
- CAI, GC content, mRNA structure, splice sites, instability motifs, restriction sites
- Timeline
- 3–5 days per sequence
- Output
- Optimised coding sequence, design report, optional A/B expression comparison
- Compatibility
- Delivered as GeneArt/IDT-compatible or synthesised directly
Related Products
- Recombinant ProteinsGrowth factors, cytokines and antigens produced across E. coli, yeast, insect and mammalian hosts — over 10,000 items on the shelf and ready to move.
- Native ProteinsIsolated directly from natural sources, preserving native post-translational modifications and conformational epitopes that recombinant systems can miss.
- Monoclonal AntibodiesRecombinant and hybridoma clones characterised for Western blot, IHC, immunofluorescence, ELISA and flow cytometry — application data included.
Next step
Tell us the target, we will tell you what is feasible
Send the sequence, assay format and sensitivity you need. You will get a technical assessment — recommended platform, timeline and the risks worth knowing before you commit budget.